INS and type 2 diabetes mellitus: Overall, the results of the present study suggest that the risk factors clustering in the metabolic syndrome acting independently of impairment of whole-body insulin sensitivity can aggravate myocardial insulin resistance in subjects with type 2 diabetes without cardiovascular disease.